https://www.fiercebiotech.com/biotech/cytodyn-ousts-ceo-after-a-wild-year-leaving-board-albatross-a-c-suite-job-to-fill
CytoDyn board ousts CEO after a wild year, leaving an albatross of a C-suite job to fill | Fierce...
Jan 26, 2022 - CytoDyn President and CEO Nader Pourhassan, Ph.D., is out, and Chief Financial Officer Antonio Migliarese is in, at least for the interim, in the latest twist...
https://markets.businessinsider.com/news/stocks/cytodyn-announces-completion-of-fda-meeting-on-phase-ii-study-of-leronlimab-in-patients-with-relapsed-refractory-microsatellite-stable-colorectal-cancer-1033676873
CytoDyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients with...
VANCOUVER, Washington, Aug. 12, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ('CytoDyn' or the 'Company'), a biotechnology company develo...
https://www.nasdaq.com/market-activity/stocks/cydy/news-headlines
Cytodyn Inc (CYDY) News Headlines | Nasdaq
Stay up-to-date on Cytodyn Inc (CYDY) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq.com.
news headlinesincnasdaq
https://www.foxbusiness.com/video/6198423662001
Potential coronavirus treatment test results to be announced next week: CytoDyn CEO | Fox Business...
Nader Pourhassan on potential new coronavirus treatment